PUBLIC CONTRACT · 2018
Vedolizumab 300 mg pó conc sol inj fr IV
- Contract value
- €122,809.60
- Signed on
- 16 March 2018
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4817273PUBLISHED SUBJECT
AQUISIÇÃO DE VEDOLIZUMAB 300 MG PÓ CONC SOL INJ FR IV
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TAKEDA-FARMACEUTICOS PORTUGAL, LDA · Tax ID 502801204
Values and timeline
- Contract price
- €122,809.60
- Procedure base price
- €122,809.60
- Total effective price
- Not reported on Portal BASE
- Publication date
- 12 September 2018
- Award date
- 8 March 2018
- Signing date
- 16 March 2018
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3608124
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.